Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
MRSA Harboring mecA Variant Gene mecC, France
  • Published Date:
    Sep 2012
  • Source:
    Emerg Infect Dis. 18(9):1465-1467.
Filetype[PDF-285.86 KB]


Details:
No Related Documents.
You May Also Like:
  1. Interim infection prevention and control guidance for veterinary clinics during the COVID-19 response
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    July 21, 2020
    Description:
    Updated July 21, 2020Summary of Recent ChangesRevisions were made on July 21, 2020 to reflect the following:• Updates were made to the recommendations for staff to stay home when they are sick to link to guidance for ending home isolation.Revisions...
    File Type:
    Filetype[PDF - 224.00 KB]
  2. Interim infection prevention and control guidance for veterinary clinics during the COVID-19 response
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    July 17, 2020
    Description:
    Updated July 17, 2020Summary of Recent ChangesRevisions were made on June 17, 2020 to reflect the following:• The time frame before an individual should return to work after no fever without fever-reducing medication was changed from at least 72 ho...
    File Type:
    Filetype[PDF - 221.80 KB]
  3. Detection and Genetic Characterization of Community-Based SARS-CoV-2 Infections — New York City, March 2020
    Personal Author:
    Bushman, Dena; Alroy, Karen A.; Greene, Sharon K.; Keating, Page; Wahnich, Amanda; Weiss, Don; Pathela, Preeti; Harrison, Christy; Rakeman, Jennifer; Langley, Gayle; Tong, Suxiang; Tao, Ying; Uehara, Anna; Queen, Krista; Paden, Clinton R.; Szymczak, Wendy; Orner, Erika P.; Nori, Priya; Lai, Phi A.; Jacobson, Jessica L.; Singh, Harjot K.; Calfee, David P.; Westblade, Lars F.; Vasovic, Ljiljana V.; Rand, Jacob H.; Liu, Dakai; Singh, Vishnu; Burns, Janice; Prasad, Nishant; Sell, Jessica;
    Corporate Authors:
    CDC COVID-19 Surge Laboratory Group;
    Published Date:
    July 17 2020
    Source:
    MMWR Morb Mortal Wkly Rep. 69(28):918-922
    Description:
    To limit introduction of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), the United States restricted travel from China on February 2, 2020, and from Europe on March 13. To determine whether local transmission of SARS-CoV-2 cou...
    File Type:
    Filetype[PDF - 241.46 KB]
  4. Symptom Profiles of a Convenience Sample of Patients with COVID-19 — United States, January–April 2020
    Personal Author:
    Burke, Rachel M.; Killerby, Marie E.; Newton, Suzanne; Ashworth, Candace E.; Berns, Abby L.; Brennan, Skyler; Bressler, Jonathan M.; Bye, Erica; Crawford, Richard; Harduar Morano, Laurel; Lewis, Nathaniel M.; Markus, Tiffanie M.; Read, Jennifer S.; Rissman, Tamara; Taylor, Joanne; Tate, Jacqueline E.; Midgley, Claire M.; Balachandran, Neha; Dahl, Rebecca M.; Dott, Mary; Gilani, Zunera; Grober, Aaron; Leung, Jessica; O’Hegarty, Michelle; Person, John; Ricaldi, Jessica N.; Roth, Nicole M.; Sejvar, James J.; Shimabukuro, Tom; Tran, Cuc H.; Watson, John T.; Whitham, Hilary; Chiou, Howard; Clogher, Paula; Duca, Lindsey M.; Dratch, Alissa; Feldpausch, Amanda; Fill, Mary-Margaret; Ghinai, Isaac; Holshue, Michelle; Scott, Sarah; Westergaard, Ryan;
    Corporate Authors:
    Case Investigation Form Working Group. Case Investigation Form Working Group. Case Investigation Form Working Group.
    Published Date:
    July 17 2020
    Source:
    MMWR Morb Mortal Wkly Rep. 69(28):904-908
    Description:
    Coronavirus disease 2019 (COVID-19) was first detected in the United States in January 2020 (1), and by mid-July, approximately 3.4 million cases had been reported in the United States (2). Information about symptoms among U.S. COVID-19 patients is l...
    File Type:
    Filetype[PDF - 194.46 KB]
  5. Vital Signs: Prescription Opioid Pain Reliever Use During Pregnancy — 34 U.S. Jurisdictions, 2019
    Personal Author:
    Ko, Jean Y.; D’Angelo, Denise V.; Haight, Sarah C.; Morrow, Brian; Cox, Shanna; Salvesen von Essen, Beatriz; Strahan, Andrea E.; Harrison, Leslie; Tevendale, Heather D.; Warner, Lee; Kroelinger, Charlan D.; Barfield, Wanda D.;
    Published Date:
    July 17 2020
    Source:
    MMWR Morb Mortal Wkly Rep. 69(28):897-903
    Description:
    Prescription opioid use during pregnancy has been associated with poor outcomes for mothers and infants. Studies using administrative data have estimated that 14%-22% of women filled a prescription for opioids during pregnancy; however, data on self-...
    File Type:
    Filetype[PDF - 335.25 KB]